A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Primary AL Amyloidosis

Clinical trial NCT07765524 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07765524
Sponsor: Shenzhen Fosun Kairos Biotechnology Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Light Chain (AL) Amyloidosis

Start date: 2026-08-01
Primary completion: 2028-03-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.